Does Cellebrite DI (CLBT) Pay a Dividend? (2026)
Last updated November 2026
Short answer
No. Cellebrite DI (CLBT) pays no dividend, so the yield is 0% and the position generates no income while you hold it. Its earnings position, ~$58 million, is the reason that matters most: companies typically start paying only once earnings and free cash flow are durable enough to support a standing commitment. All of CLBT's return has to come from the share price. Verify the current policy on CLBT's investor relations page.
Does Cellebrite DI (CLBT) pay a dividend?
No. There is no dividend on CLBT in our data and the yield is 0%. At about $10.91 on October 16, 2026, Cellebrite trades near 4.5x trailing revenue on enterprise value and about 17x forward earnings, well below the ~7x revenue multiple it carried in mid-2026 before the guidance cut. Consensus for 2026 is about $557 million of revenue and $0.55 of EPS, rising to roughly $641 million and $0.65 in 2027. Third-quarter results are expected around November 11, 2026, with consensus near $0.16 EPS on about $146 million of revenue; the seven covering analysts carry a mean target near $15.
Plainly: if you are holding CLBT for income, it does not provide any. The only way a position in it puts cash in your pocket is if you sell shares.
Why CLBT pays no dividend
Cellebrite DI's earnings position (~$58 million) is the constraint. On cash flow: ~$125 million. A dividend is a standing commitment that a board is very reluctant to cut once started, because a cut is read as a signal about the business. Companies therefore wait until profits and free cash flow are durable before starting one, and many never do, preferring buybacks, which can be paused without the same signalling cost.
Retaining cash is not a weakness in itself. A company that can reinvest a dollar at a high return creates more value by keeping it than by paying it out. The question is whether Cellebrite DI is actually earning that return on what it reinvests, which is a business question, not a dividend question.
What would have to change for CLBT to start paying
Consistent profitability first, then free cash flow that comfortably exceeds what the business needs to keep growing, and then a management view that it has run out of better uses for the money. Those show up in the quarterly numbers well before any announcement, so the results are the place to watch. The press releases come later. We are not predicting whether or when that happens.
Where investors get income instead
The common approach is to hold CLBT for the growth exposure and get income from somewhere else in the portfolio, so each position does one job. The income side means dividend-paying stocks, dividend ETFs, or short-term bond and Treasury funds, sized so the income side covers what you need.
- Best dividend stocks for individual payers with long records.
- Best dividend ETFs to get a spread of payers in one holding.
- Best ETFs for monthly income if the timing of the cash matters to you.
Walnut is informational and is not an investment adviser. None of these are recommendations.
Tax: what a zero-dividend stock changes
With no dividend there is no income to report while you hold CLBT, so nothing is taxable until you sell. At sale you owe capital-gains tax on the gain, at long-term rates if you held for more than a year. Compared with a dividend payer in a taxable account, which generates a tax bill every year whether you spend the cash or reinvest it, that deferral is a small structural advantage. See how stocks are taxed. This is not tax advice.
The bottom line on the CLBT dividend
There is not one. Cellebrite DI (CLBT) is a total-return holding: it either works through the share price or it does not work. If you own it, own it for that reason, and build the income part of your portfolio elsewhere. For the full picture see the CLBT guide. Walnut can show how CLBT fits your real portfolio. It is not an investment adviser.
Investing in Cellebrite DI with AI
Connect the broker you already use and ask Walnut's AI how CLBT fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Does Cellebrite DI (CLBT) pay a dividend?
+
No. Cellebrite DI has no dividend on record, so the yield is 0% and holding CLBT produces no income. Cellebrite DI directs its cash back into the business, through research, capacity, acquisitions, or buybacks. Every dollar of return from CLBT has to come from the share price. Verify the current policy on CLBT's investor relations page, since a board can start a dividend at any time.
Why doesn't CLBT pay a dividend?
+
Cellebrite DI directs its cash back into the business, through research, capacity, acquisitions, or buybacks. Its free cash flow position (~$125 million) is the constraint that matters most here: a dividend is a standing commitment, and starting one before cash generation is reliable would mean funding it from the balance sheet. Paying nothing is a deliberate choice, not a failure. A growth company that can reinvest at high returns creates more value per dollar retained than it would by handing that dollar to shareholders.
Will CLBT ever pay a dividend?
+
Nobody can say, and we will not guess. What usually has to happen first is a stretch of durable profitability and positive free cash flow, with enough left over after reinvestment that the company runs out of better uses for the money. Those show up in the quarterly results well before any announcement. Companies also often start with buybacks before a dividend, because a buyback carries no ongoing commitment.
What is CLBT's dividend yield?
+
0%. There is no dividend, so there is no yield. This matters for planning: if you are building an income portfolio, CLBT contributes nothing to the income side and its entire contribution is price return. It also means the position generates no taxable income while you hold it.
How do I get income if I own CLBT?
+
The usual approach is to pair a non-payer like CLBT with holdings that do pay: dividend stocks, dividend ETFs, or bond funds, sized so the income side of the portfolio meets your needs while the growth side stays intact. Some investors sell covered calls on positions they hold, though that caps the upside that is the whole reason to own a growth name. See our guides to the best dividend stocks and best dividend ETFs. Walnut is not an investment adviser.
Do I owe tax on CLBT if it pays no dividend?
+
Not while you hold it. With no dividend there is no income to report, so nothing is taxable until you sell. At that point you owe capital-gains tax on the gain, at long-term rates if you held for more than a year and at ordinary-income rates if you did not. That deferral is a genuine, if minor, advantage of non-payers in a taxable account. This is not tax advice.
Is CLBT a bad stock for income investors?
+
It is the wrong tool for that job, which is not the same as a bad company. If you need cash from your portfolio, a stock paying nothing forces you to sell shares to generate it, which means selling into whatever price the market happens to offer. Investors who want CLBT's growth exposure and also want income typically hold both kinds of position and give each one job.
Does CLBT pay a dividend?
+
No. Cellebrite has not paid a dividend and retains cash for product development and acquisitions, such as the ~$170 million Corellium purchase completed in late 2025. Its cash balance, about $443 million at mid-2026 against roughly $23 million of debt, is held as a war chest rather than distributed to shareholders.
Walnut is informational, not investment advice. Dividend figures on this page come from a November 2026 data pull and are approximate; verify the current yield, amount, schedule, and policy with CLBT's investor relations page or your broker before acting on them.